For the Inventor, By the Inventor

Enter assignee name

Richmond, CA, United States of America

Lxr Biotechnology, Inc.

USPTO Granted Patents = 17

Forward Citations = 145

Loading Chart...

Loading Chart...

10 inventors (with patents filed for the assignee):

Philip J Barr (13 out of 65 patents)

L David Tomei (11 out of 12 patents)

Ian C Bathurst (8 out of 14 patents)

4. John D Bradley (7 out of 37 patents)

5. Michael C Kiefer (5 out of 43 patents)

6. John P Shapiro (2 out of 2 patents)

7. Mauro Piacentini (1 out of 2 patents)

8. John G Goddard (1 out of 3 patents)

9. Matthew W Foehr (1 out of 6 patents)

10. Laszlo Fesus (1 out of 1 patent)

17 patents: Sort by Forward Citations

1. 6306398 - Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof (2001-10-23),

2. 6015687 - Apoptosis-modulating proteins, DNA encoding the proteins and methods of (2000-01-18),

3. 6004579 - Compositions which inhibit apoptosis, methods of making the compositions (1999-12-21),

4. 5998131 - Screening methods for the identification of compounds capable of (1999-12-07),

5. 5770443 - Apoptosis-modulating proteins, DNA encoding the proteins and methods of (1998-06-23),

6. 5759548 - Compositions which inhibit apoptosis, methods of purifying the (1998-06-02),

7. 5750360 - Method for quantitatively measuring apoptosis (1998-05-12),

8. 5681703 - Methods of identifying potentially therapeutically effective agents and (1997-10-28),

9. 5663070 - Recombinant production of a soluble splice variant of the Fas (Apo-1) (1997-09-02),

10. 5652210 - Soluble splice variant of the Fas (APO-1) antigen, Fas.DELTA.TM (1997-07-29),

11. 5637486 - Methods of identifying potentially therapeutically effective agents and (1997-06-10),

12. 5635187 - Compositions which inhibit apoptosis, methods of purifying the (1997-06-03),

13. 5635186 - Compositions which inhibit apoptosis, methods of purifying the (1997-06-03),

14. 5624672 - Compositions which inhibit apoptosis, methods of purifying the (1997-04-29),

15. 5620888 - Cell strains for use in identifying potentially therapeutically (1997-04-15),

Lxr Biotechnology, Inc. is a leading biotechnology company dedicated to developing innovative therapies for a range of diseases. Our focus is on research and development in the fields of genetics, genomics, and bioinformatics to create personalized treatments for patients. With a team of experienced scientists and cutting-edge technology, we strive to make a positive impact on healthcare and improve quality of life for individuals worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

17 Patents

#16 in Richmond, CA

#4,371 in California

#18,293 in US

#34,805 in the World

Richmond, CA, United States of America

Lxr Biotechnology, Inc.

Forward Citations = 145

10 inventors:

Philip J Barr (13 out of 65 patents)

L David Tomei (11 out of 12 patents)

Ian C Bathurst (8 out of 14 patents)

4. John D Bradley (7 out of 37 patents)

5. Michael C Kiefer (5 out of 43 patents)

Please report any incorrect information to support@idiyas.com

Loading…